The overall aim is to evaluate a newly developed integrated care approach using an electronic, personal health record in combination with an computer-assisted and evidence based diabetes risk management instrument for patients with type 2 diabetes. The impact of the intervention will be explored.
To gain this information we use a prospective, cluster randomised, longitudinal, controlled trial design with baseline measurement and one and a half years follow-up on relevant outcome measures. Approximately 37 general practitioners and 400-600 of their outpatient, type 2 diabetes patients will be enrolled. The intervention group will continuously measure relevant risk parameters with electronic measurement devices and use risk and potential reports generated by a computer-assisted diabetes risk management software during the consultations. A multilevel analysis will evaluate the effect of the intervention.

The study is registered at the German Clinical Trials Register. Its register ID is: DRKS00000056